Buy Ecstasy Strasbourg

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buy Ecstasy Strasbourg

These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format. All countries. Topics A-Z. The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses. Best practice. We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon. Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it. All publications. More events. More news. We are your source of drug-related expertise in Europe. We prepare and share independent, scientifically validated knowledge, alerts and recommendations. About the EUDA. Drug consumption rooms, sometimes known as supervised injecting facilities, are fixed or mobile spaces in which people who inject drugs are provided with sterile injection equipment and can use illicit drugs under the supervision of trained staff. In some countries, consumption rooms also provide a space and equipment to allow non-injecting routes of administration, for example for crack cocaine smokers. Drug consumption rooms exist in several European countries and are usually located in areas where there is an open drug scene and injecting in public places is common. Their primary goal is to reduce morbidity and mortality by providing a safer environment for drug use and training clients in safer forms of drug use. Providing a conduit to other care services and reducing public nuisance may also be an explicit objective. Their aims were to reduce the risks of unhygienic injecting, prevent fatal overdoses and the spread of infectious diseases, and link drug users with treatment, health and social services. More recently, in some countries, provision has also been provided for other routes of administration such as smoking or inhaling drugs. The establishment of drug consumption rooms has sometimes been opposed by local communities because of fears that they might aggravate open drug scenes. However, counterarguments have been made that these facilities may reduce the harms to communities associated with public drug injecting. Access to consumption facilities may be restricted to registered service users, and often certain conditions have to be met, for example minimum age and local residency. Typically, drugs used in these facilities must be obtained prior to entry. Drug dealing and drug sharing are not allowed within the facilities staff may be required to engage the police if necessary , and staff cannot assist clients in administering their drugs. Drug consumption rooms are usually staffed by nurses and social workers, but doctors, security staff and peer workers may also be part of the team. Other professional groups may also be represented. Opening hours and the number of daily visits vary considerably across jurisdictions and between facilities. Drug consumption rooms have been operating in Europe since , when the first one was established in Bern, Switzerland. Since then, Norway and an increasing number of EU countries have opened facilities in one or more of their cities. As frontline, low-threshold services, drug consumption rooms are often among the first to gain insights into new drug use patterns and, thus, they have a role to play in the early identification of new and emerging trends among high-risk populations using their services. As rates of injecting in some countries decrease, consideration has been given to using drug consumption rooms to reduce harms associated with other routes of administration e. This implies some changes in the aims of this response, and research and evaluation will be necessary to assess the effectiveness of this approach with non-injecting populations. More generally, despite the difficulties of conducting research in this setting, more studies are needed to improve the evidence on the extent to which they reduce individual and community harms, both for outcomes associated with drug injecting and those associated with non-injecting routes of administration. This page provides an overview of key issues related to drug consumption rooms, including service delivery, guidance and existing evidence and latest developments in Europe. It also considers implications for policy and practice. Homepage Quick links Quick links. GO Results hosted on duckduckgo. Main navigation Data Open related submenu Data. Latest data Prevalence of drug use Drug-induced deaths Infectious diseases Problem drug use Treatment demand Seizures of drugs Price, purity and potency. Drug use and prison Drug law offences Health and social responses Drug checking Hospital emergencies data Syringe residues data Wastewater analysis Data catalogue. Selected topics Alternatives to coercive sanctions Cannabis Cannabis policy Cocaine Darknet markets Drug checking Drug consumption facilities Drug markets Drug-related deaths Drug-related infectious diseases. Recently published Findings from a scoping literature…. Penalties at a glance. Frequently asked questions FAQ : drug…. FAQ: therapeutic use of psychedelic…. Viral hepatitis elimination barometer…. EU Drug Market: New psychoactive…. EU Drug Market: Drivers and facilitators. Statistical Bulletin home. Quick links Search news Subscribe newsletter for recent news Subscribe to news releases. Breadcrumb Home Topics Drug consumption facilities. On this page. Drug consumption facilities. Overview Drug consumption rooms, sometimes known as supervised injecting facilities, are fixed or mobile spaces in which people who inject drugs are provided with sterile injection equipment and can use illicit drugs under the supervision of trained staff. More information. What are drug consumption rooms? What problems do they address? What services are typically provided? A safer environment for drug use. Provision of sterile injecting equipment. Intervention in overdoses that occur on-site. Counselling services. Primary medical care. Training for clients in safer forms of drug use, overdose awareness and the use of naloxone. Referral of clients to appropriate social, healthcare and treatment services. Some drug consumption rooms also promote engagement in opioid agonist treatment. Other frequently provided services include tea and coffee, use of a phone, and the possibility to take a shower and wash clothes. Conditions and access Access to consumption facilities may be restricted to registered service users, and often certain conditions have to be met, for example minimum age and local residency. Operational models Three operational models are typically used in Europe: integrated services, operating from separate areas attached to low-threshold facilities, where supervision of drug consumption is one of several services offered; specialised services, only offering the narrower range of services directly related to supervised consumption; mobile services, providing a geographically flexible deployment of the service, but typically catering for a more limited number of clients than fixed premises. Drug consumption rooms in Europe Drug consumption rooms have been operating in Europe since , when the first one was established in Bern, Switzerland. Looking to the future As frontline, low-threshold services, drug consumption rooms are often among the first to gain insights into new drug use patterns and, thus, they have a role to play in the early identification of new and emerging trends among high-risk populations using their services. Related topics Harm reduction Drug-related deaths and mortality Drug-related infectious diseases Naloxone take-home. Health and social responses: drug consumption rooms This page provides an overview of key issues related to drug consumption rooms, including service delivery, guidance and existing evidence and latest developments in Europe. Read this page. Harm reduction — the current situation in Europe European Drug Report Health and social responses: drug consumption rooms. Cocaine — the current situation in Europe European Drug Report Joint report on drug consumption rooms. Evidence for the effectiveness of interventions to prevent infections among people who inject drugs: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour. Evidence database of the Best practice portal. European Drug Report Trends and Developments. Preventing overdose deaths in Europe Perspectives on drugs. Drug consumption rooms: an overview of provision and evidence Perspectives on drugs. Harm reduction: evidence, impacts and challenges. Read our most recent news on this topic. New report presents latest overview on drug consumption rooms in Europe December Key interventions to prevent and control infections among people who inject drugs November Drug overdoses can be prevented — new resources released August Related events, meetings, conferences and more from our events calendar. Symposium 'Low risk drug consumption rooms in Europe: Assessments and prospects' 03 Apr , Strasbourg. No results found for your current search criteria. Consider broadening your search. European Drug Report Trends and Developments: source data. Documents on this topic in our Document Library. Drug consumption rooms: A systematic review of evaluation methodologies Evaluation of drug consumption rooms Denmark Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking Photos, infographics and videos from our Media library. Number of European countries implementing harm reduction interventions, up to Location and number of drug consumption facilities throughout Europe. Infographics: Interventions in place in European countries that can reduce opioid-related deaths.